Alfacyte
Glasgow
About Alfacyte
Alfacyte Ltd. develops an immunoregulatory formulation for the oral treatment of food allergies based on the immunological activities of two candidate cytokines, with adjuvant-like activities. Its immunoregulatory combination therapy is used for the oral treatment of peanut allergy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $308.1K
- Last round: Series Unknown (Jan 2017)
- Website: alfacyte.com
- Phone: +441413038213
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/alfacyte-2231365 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.